Literature DB >> 12638938

Glucose-free medium exacerbates microvesicular steatosis in cultured skin fibroblasts of genetic defects of fatty acid oxidation. A novel screening test.

D L Renaud1, V Edwards, G J Wilson, I Tein.   

Abstract

Skin fibroblasts from patients with various fatty acid oxidation defects (FAOD) and four normal controls were subcultured in standard glucose-containing medium or in glucose-free medium simulating fasting. The FAOD fibroblasts developed microvesicular steatosis, which was greatly exacerbated in glucose-free medium. 'Rescue treatment' with glucose-containing medium was performed in the short-chain L-3-hydroxyacyl-CoA dehydrogenase-deficient (SCHADD) fibroblasts and resulted in a partial resolution of the steatosis and improved cellular viability. Transmission electron microscopy of autopsy specimens from the SCHADD patient demonstrated that most renal interstitial fibroblasts and approximately 50% of fibroblasts in the heart had microvesicular steatosis. The demonstration of microvesicular steatosis in parenchymal and/or cultured skin fibroblasts may provide important and cost-effective screening tools for the detection of genetic defects of fatty acid oxidation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12638938     DOI: 10.1023/a:1022039206660

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  17 in total

1.  Postmortem recognition of fatty acid oxidation disorders.

Authors:  M J Bennett; D E Hale; P M Coates; C A Stanley
Journal:  Pediatr Pathol       Date:  1991 May-Jun

Review 2.  Clinical and biochemical features of fatty acid oxidation disorders.

Authors:  P Rinaldo; K Raymond; A al-Odaib; M J Bennett
Journal:  Curr Opin Pediatr       Date:  1998-12       Impact factor: 2.856

3.  Sudden neonatal death in carnitine transporter deficiency.

Authors:  P Rinaldo; C A Stanley; B Y Hsu; L A Sanchez; H J Stern
Journal:  J Pediatr       Date:  1997-08       Impact factor: 4.406

4.  Pathology of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency caused by the G1528C mutation.

Authors:  T Tyni; J Rapola; A Paetau; A Palotie; H Pihko
Journal:  Pediatr Pathol Lab Med       Date:  1997 May-Jun

Review 5.  The changing face of disorders of fatty acid oxidation.

Authors:  J Vockley
Journal:  Mayo Clin Proc       Date:  1994-03       Impact factor: 7.616

Review 6.  Sudden and unexpected neonatal death: a protocol for the postmortem diagnosis of fatty acid oxidation disorders.

Authors:  P Rinaldo; H R Yoon; C Yu; K Raymond; C Tiozzo; G Giordano
Journal:  Semin Perinatol       Date:  1999-04       Impact factor: 3.300

7.  Intrinsic alcohol dehydrogenase and hydroxysteroid dehydrogenase activities of human mitochondrial short-chain L-3-hydroxyacyl-CoA dehydrogenase.

Authors:  X Y He; Y Z Yang; H Schulz; S Y Yang
Journal:  Biochem J       Date:  2000-01-01       Impact factor: 3.857

8.  Structural organization of the human short-chain L-3-hydroxyacyl-CoA dehydrogenase gene.

Authors:  P J Vredendaal; I E van den Berg; A K Stroobants; D L van der A; H E Malingré; R Berger
Journal:  Mamm Genome       Date:  1998-09       Impact factor: 2.957

9.  Relationship between donor age and the replicative lifespan of human cells in culture: a reevaluation.

Authors:  V J Cristofalo; R G Allen; R J Pignolo; B G Martin; J C Beck
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

10.  Short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency in muscle: a new cause for recurrent myoglobinuria and encephalopathy.

Authors:  I Tein; D C De Vivo; D E Hale; J T Clarke; H Zinman; R Laxer; A Shore; S DiMauro
Journal:  Ann Neurol       Date:  1991-09       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.